EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Expanding the Genotypic Spectrum of POMGNT1‐Related Muscle‐Eye‐Brain Disease: A Case Report

Evripidis Pityrigkas, Vasiliki Poulidou iD, Stefania Kalampokini, Eleni Liouta, Georgia Pepe, Martha Spilioti, Vasilios K Kimiskidis iD

Molecular Genetics & Genomic Medicine · 2026

DOI: 10.1002/mgg3.70256 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Evripidis Pityrigkas und 6 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: N-Acetylglucosaminyltransferases, Walker-Warburg Syndrome. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Muscle‐Eye‐Brain disease (MEB) is a rare autosomal recessive dystroglycanopathy caused by defective glycosylation of α‐dystroglycan, leading to a multisystem disorder involving the central nervous system, skeletal muscle, and eyes. It represents an important cause of developmental and epileptic encephalopathy, with variable clinical severity and genetic heterogeneity, most commonly associated with variants in the POMGNT1 gene.

Methods

Clinical, neurophysiological, neuroimaging, histopathological, and genetic investigations were performed, including targeted next‐generation sequencing for congenital muscular dystrophy‐associated genes.

Results

The patient presented with early‐onset hypotonia, global developmental delay, progressive motor regression, intellectual disability, and ocular abnormalities. Epilepsy onset occurred in childhood and evolved into drug‐resistant epilepsy with status epilepticus in adulthood. Brain MRI revealed lissencephaly, ventriculomegaly, and brainstem and cerebellar hypoplasia. EEG demonstrated features consistent with epileptic encephalopathy. Genetic testing identified compound heterozygosity for the POMGNT1 variants c.1282C>T, p.(Gln428*) and c.793C>T, p.(Arg265Cys). Seizure control was eventually achieved with polytherapy including four antiseizure medications.

Conclusion

This case expands the genotypic and phenotypic spectrum of POMGNT1 ‐related MEB, highlighting the potential for severe epilepsy and status epilepticus in adulthood. It also underscores the importance of long‐term clinical follow‐up and suggests that aggressive antiseizure treatment may achieve seizure control even in advanced stages of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-AcetylglucosaminyltransferasesWalker-Warburg SyndromeHumansGenotypePhenotype

Stichwörter der Autor:innen

POMGNT1developmental and epileptic encephalopathydystroglycanopathymuscle‐eye‐brain disease

Substanzen

N-Acetylglucosaminyltransferasesprotein O-mannose beta-1,2-N-acetylglucosaminyltransferase

Autor:innen und Institutionen

  • First Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Genekor Medical S.A., Athens, Greece.

ORCID-Profile: Vasiliki Poulidou, Vasilios K Kimiskidis

Zitieren

APA

Pityrigkas, E., Poulidou, V., Kalampokini, S., Liouta, E., Pepe, G., Spilioti, M., & Kimiskidis, V. K. (2026). Expanding the Genotypic Spectrum of POMGNT1‐Related Muscle‐Eye‐Brain Disease: A Case Report. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70256

Vancouver

Pityrigkas E, Poulidou V, Kalampokini S, Liouta E, Pepe G, Spilioti M, et al. Expanding the Genotypic Spectrum of POMGNT1‐Related Muscle‐Eye‐Brain Disease: A Case Report. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70256

BibTeX
@article{Pityrigkas2026,
  author = {Pityrigkas, Evripidis and Poulidou, Vasiliki and Kalampokini, Stefania and Liouta, Eleni and Pepe, Georgia and Spilioti, Martha and Kimiskidis, Vasilios K},
  title = {Expanding the Genotypic Spectrum of POMGNT1‐Related Muscle‐Eye‐Brain Disease: A Case Report},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  doi = {10.1002/mgg3.70256}
}
Kostenlos starten →